GB0020588D0 - Treatment of wounds - Google Patents
Treatment of woundsInfo
- Publication number
- GB0020588D0 GB0020588D0 GBGB0020588.0A GB0020588A GB0020588D0 GB 0020588 D0 GB0020588 D0 GB 0020588D0 GB 0020588 A GB0020588 A GB 0020588A GB 0020588 D0 GB0020588 D0 GB 0020588D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- wounds
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010052428 Wound Diseases 0.000 title 1
- 208000027418 Wounds and injury Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0020588.0A GB0020588D0 (en) | 2000-08-21 | 2000-08-21 | Treatment of wounds |
US09/927,344 US20020065286A1 (en) | 2000-08-21 | 2001-08-10 | Treatment of wounds |
IL15401101A IL154011A0 (en) | 2000-08-21 | 2001-08-16 | Treatment of wounds |
CA002415791A CA2415791A1 (en) | 2000-08-21 | 2001-08-16 | Treatment of wounds |
JP2002520814A JP2004519425A (en) | 2000-08-21 | 2001-08-16 | Wound healing |
AU2001276636A AU2001276636A1 (en) | 2000-08-21 | 2001-08-16 | Treatment of wounds |
HU0303029A HUP0303029A3 (en) | 2000-08-21 | 2001-08-16 | Use of pharmaceutical compositions containing cgmp-5pde inhibitors for treatment of wounds |
EP01954296A EP1311252A2 (en) | 2000-08-21 | 2001-08-16 | Treatment of wounds |
PCT/IB2001/001470 WO2002015893A2 (en) | 2000-08-21 | 2001-08-16 | Treatment of wounds |
KR10-2003-7002520A KR20030097778A (en) | 2000-08-21 | 2001-08-16 | Treatment of wounds |
ZA200301156A ZA200301156B (en) | 2000-08-21 | 2003-02-12 | Treatment of wounds. |
US10/928,028 US20050148585A1 (en) | 2000-08-21 | 2004-08-26 | Treatment of wounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0020588.0A GB0020588D0 (en) | 2000-08-21 | 2000-08-21 | Treatment of wounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0020588D0 true GB0020588D0 (en) | 2000-10-11 |
Family
ID=9898022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0020588.0A Ceased GB0020588D0 (en) | 2000-08-21 | 2000-08-21 | Treatment of wounds |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1311252A2 (en) |
JP (1) | JP2004519425A (en) |
KR (1) | KR20030097778A (en) |
AU (1) | AU2001276636A1 (en) |
CA (1) | CA2415791A1 (en) |
GB (1) | GB0020588D0 (en) |
HU (1) | HUP0303029A3 (en) |
IL (1) | IL154011A0 (en) |
WO (1) | WO2002015893A2 (en) |
ZA (1) | ZA200301156B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8133903B2 (en) | 2003-10-21 | 2012-03-13 | Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center | Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases |
TWI339578B (en) | 2004-10-29 | 2011-04-01 | Mitsubishi Tanabe Pharma Corp | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
GB2459098A (en) * | 2008-04-08 | 2009-10-14 | Ethicon Inc | Genetic markers of wound development |
WO2010062366A1 (en) * | 2008-10-31 | 2010-06-03 | Arginetix, Inc. | Compositions and methods of treating endothelial disorders |
CN102970965A (en) | 2010-04-05 | 2013-03-13 | Sk化学公司 | Composition containing PDE5 inhibitor for relieving skin wrinkles |
AT512084A1 (en) | 2011-10-20 | 2013-05-15 | Univ Wien Tech | DIAZABICYCLO AND DIAZASPIRO ALKAN DERIVATIVES AS PHOSPHODIESTERASE-5 INHIBITORS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2333041A (en) * | 1998-01-13 | 1999-07-14 | Johnson & Johnson Medical Ltd | Wound Composition |
WO2000015639A1 (en) * | 1998-09-16 | 2000-03-23 | Icos Corporation | Carboline derivatives as cgmp phosphodiesterase inhibitors |
AU764921B2 (en) * | 1998-12-14 | 2003-09-04 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
GB0000561D0 (en) * | 2000-01-11 | 2000-03-01 | Pfizer Ltd | Treatment of diabetic ulcers |
US6774128B2 (en) * | 2000-04-19 | 2004-08-10 | Johns Hopkins University | Methods for prevention and treatment of gastrointestinal disorders |
AU2001268064A1 (en) * | 2000-06-07 | 2001-12-17 | Lilly Icos Llc | Derivatives of 2,3,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione |
IL153426A0 (en) * | 2000-06-30 | 2003-07-06 | Pfizer | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
JP2004516244A (en) * | 2000-07-31 | 2004-06-03 | セレジィ ファーマシューティカルス, インコーポレイテッド | Compositions and methods for the treatment of anorectal disorders |
-
2000
- 2000-08-21 GB GBGB0020588.0A patent/GB0020588D0/en not_active Ceased
-
2001
- 2001-08-16 IL IL15401101A patent/IL154011A0/en unknown
- 2001-08-16 CA CA002415791A patent/CA2415791A1/en not_active Abandoned
- 2001-08-16 AU AU2001276636A patent/AU2001276636A1/en not_active Abandoned
- 2001-08-16 WO PCT/IB2001/001470 patent/WO2002015893A2/en not_active Application Discontinuation
- 2001-08-16 EP EP01954296A patent/EP1311252A2/en not_active Withdrawn
- 2001-08-16 HU HU0303029A patent/HUP0303029A3/en unknown
- 2001-08-16 KR KR10-2003-7002520A patent/KR20030097778A/en not_active Application Discontinuation
- 2001-08-16 JP JP2002520814A patent/JP2004519425A/en not_active Withdrawn
-
2003
- 2003-02-12 ZA ZA200301156A patent/ZA200301156B/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0303029A3 (en) | 2004-11-29 |
AU2001276636A1 (en) | 2002-03-04 |
WO2002015893A3 (en) | 2003-03-13 |
ZA200301156B (en) | 2004-04-16 |
JP2004519425A (en) | 2004-07-02 |
EP1311252A2 (en) | 2003-05-21 |
CA2415791A1 (en) | 2002-02-28 |
KR20030097778A (en) | 2003-12-31 |
IL154011A0 (en) | 2003-07-31 |
HUP0303029A2 (en) | 2003-12-29 |
WO2002015893A2 (en) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002342613A8 (en) | Treatment for wounds | |
EP1267798A4 (en) | Treatment of skin damage using polyenylphosphatidylcholine | |
AU7434101A (en) | Treatment of bone diseases | |
AU7863201A (en) | Treatment of hyperproliferative diseases | |
IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
AU5464601A (en) | Treatment of scale | |
IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
AU5000001A (en) | Treatment of vitiligo | |
GB0001710D0 (en) | Therapeutic treatment | |
IL150479A0 (en) | Treatment of psoriasis | |
NZ513686A (en) | Treatment of trauma | |
GB2360453B (en) | Treatment of skin conditions | |
GB0020588D0 (en) | Treatment of wounds | |
AU2096002A (en) | Therapeutic treatment | |
GB0114231D0 (en) | Treatment of multiple sclerosis | |
GB2381455B (en) | Treatment of burns | |
EP1303281A4 (en) | Methods of treatment | |
GB0031321D0 (en) | Treatment | |
GB0014904D0 (en) | Methods of treatment | |
GB0013928D0 (en) | Methods of treatment | |
AUPR008500A0 (en) | Treatment of pathogens | |
EP1284748A4 (en) | Treatment of damaged connective tissue | |
AU2638002A (en) | Tissue treatment | |
AU6191201A (en) | Treatment of effluent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |